[Management of moderate and severe dysthyroid orbitopathy: about 22 cases].

about

[Management of moderate and severe dysthyroid orbitopathy: about 22 cases].

Item

http://www.wikidata.org/entity/Q46190198

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

[Management of moderate and severe dysthyroid orbitopathy: about 22 cases].

@en

[Management of moderate and severe dysthyroid orbitopathy: about 22 cases].

@nl

type

Item

label

[Management of moderate and severe dysthyroid orbitopathy: about 22 cases].

@en

[Management of moderate and severe dysthyroid orbitopathy: about 22 cases].

@nl

prefLabel

[Management of moderate and severe dysthyroid orbitopathy: about 22 cases].

@en

[Management of moderate and severe dysthyroid orbitopathy: about 22 cases].

@nl

P1476

[Management of moderate and severe dysthyroid orbitopathy: about 22 cases].

@en

P2093

Faten Gatfaoui

http://www.w3.org/2001/XMLSchema#string

Hechmi Mahjoub

http://www.w3.org/2001/XMLSchema#string

Leila Knani

http://www.w3.org/2001/XMLSchema#string

Nadia Daldoul

http://www.w3.org/2001/XMLSchema#string

P2860

A single technique to correct various degrees of upper lid retraction in patients with Graves' orbitopathy

Ophthalmological evaluation in thyroid-associated ophthalmopathy.

Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.

The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy

Orbital Volumetry in Graves' Orbitopathy: Muscle and Fat Involvement in relation to Dysthyroid Optic Neuropathy.

Clinical review: Intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity.

Evaluating Graves' orbitopathy.

Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy.

Surgical treatment of Graves' ophthalmopathy.

Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage.

P304

257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.11604/PAMJ.2017.27.257.13008

http://www.w3.org/2001/XMLSchema#string

P407

Af-Faransiis

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29187926

http://www.w3.org/2001/XMLSchema#string

P932

5660303

http://www.w3.org/2001/XMLSchema#string